Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary J Laughlin

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Cytotherapy|November 3, 2009
Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivoMarcie R Finney, Laura R Fanning, Matthew E Joseph, et al.
Stem Cells (Dayton, Ohio)|November 29, 2002
Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(-) early progenitors cultured over human MSCs as a feeder layerSuzanne Kadereit, Linda S Deeds, Stephen E Haynesworth, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2004
High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortalityPunit D Wadhwa, Pingfu Fu, Omer N Koc, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemiaMarcie R Finney, Nicholas J Greco, Stephen E Haynesworth, et al.
Blood|December 11, 2012
Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemiaAndromachi Scaradavou, Claudio G Brunstein, Mary Eapen, et al.
Blood|April 13, 2012
Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomesClaudio G Brunstein, Mary Eapen, Kwang Woo Ahn, et al.
American Journal of Hematology|April 28, 2009
Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogeneticsCrawford J Strunk, Uwe Platzbecker, Christian Thiede, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemiaDavid A Rizzieri, Adam J Bass, Gary L Rosner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2011
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignanciesJakob R Passweg, Mei-Jie Zhang, Vanderson Rocha, et al.
Biotechniques|February 6, 2015
RNAPro•SAL: a device for rapid and standardized collection of saliva RNA and proteinsSamantha H Chiang, Gerald A Thomas, Wei Liao, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Cytotherapy|November 3, 2009
Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivoMarcie R Finney, Laura R Fanning, Matthew E Joseph, et al.
Stem Cells (Dayton, Ohio)|November 29, 2002
Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(-) early progenitors cultured over human MSCs as a feeder layerSuzanne Kadereit, Linda S Deeds, Stephen E Haynesworth, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2004
High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortalityPunit D Wadhwa, Pingfu Fu, Omer N Koc, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemiaMarcie R Finney, Nicholas J Greco, Stephen E Haynesworth, et al.
Blood|December 11, 2012
Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemiaAndromachi Scaradavou, Claudio G Brunstein, Mary Eapen, et al.
Blood|April 13, 2012
Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomesClaudio G Brunstein, Mary Eapen, Kwang Woo Ahn, et al.
American Journal of Hematology|April 28, 2009
Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogeneticsCrawford J Strunk, Uwe Platzbecker, Christian Thiede, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemiaDavid A Rizzieri, Adam J Bass, Gary L Rosner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2011
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignanciesJakob R Passweg, Mei-Jie Zhang, Vanderson Rocha, et al.
Biotechniques|February 6, 2015
RNAPro•SAL: a device for rapid and standardized collection of saliva RNA and proteinsSamantha H Chiang, Gerald A Thomas, Wei Liao, et al.
Pageof 6